Mintz Levin is hosting a three-part series focused on financing for life sciences companies from initial funding to IPO via private sources, non-traditional IPO's, and traditional IPO's.
In part two of the series, we will focus on Going Public Through a Non-Traditional IPO.
Initial Public Offerings are a great way to raise money for your life sciences business. However doing a traditional IPO may be difficult for some earlier stage companies and even seasoned companies in a difficult IPO market. At this program we will discuss alternative ways to raise money in the public markets and create liquidity for you and your investors that may be more suitable for earlier stage life science companies. Come hear our panel explain your options and show you how to maximize your opportunity for a successful transaction.